CAR-T and engineered T cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

249 papers

Showing 205-216 of total 249 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2023OpenAlexDirectly related

Tingting Zhang; Weiwei Tian; Shuang Wei; Xinyi Lu; Jing An; Shaolong He; Jie Zhao; Zhilin Gao; Li Li; Ke Lian; Qiang Zhou; Huilai Zhang; Liang Wang; Liping Su; Huicong Kang; Ting Niu; Ailin Zhao; Jing Pan; Qingqing Cai; Zhenshu Xu; Wen-Ming Chen; Hongmei Jing; Peng Li; Wanhong Zhao; Yang Cao; Jian‐Qing Mi; Tao Chen; Yuan Chen; Ping Zou; Veronika Lukacs‐Kornek; Christian Kurts; Li J; Xiansheng Liu; Qi Mei; Yicheng Zhang; Wei Jia

Jul 27, 2023Experimental Hematology and Oncology

2023CrossrefDirectly related7 citations

Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt’s lymphoma with TP53 mutations

Qi Zhang; Xiaojian Zhu; Bo Liu; Yicheng Zhang; Yi Xiao

Mar 17, 2023Frontiers in Immunology

2023OpenAlexDirectly related439 citations

TCR-engineered T cell therapy in solid tumors: State of the art and perspectives

Estelle Baulu; Célia Gardet; Nicolas Chuvin; Stéphane Depil

Feb 15, 2023Science Advances

2022Semantic ScholarDirectly related128 citations

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

B. Sworder; D. Kurtz; S. Alig; M. Frank; Navika D. Shukla; A. Garofalo; C. Macaulay; Mohammad Shahrokh Esfahani; M. Olsen; J. Hamilton; H. Hosoya; Mark Hamilton; J. Spiegel; J. Baird; T. Sugio; M. Carleton; Alexander F. M. Craig; S. Younes; B. Sahaf; N. Sheybani; J. Schroers-Martin; C. Liu; J. Oak; M. Jin; S. Beygi; Andreas Hüttmann; C. Hanoun; Ulrich Dührsen; J. Westin; M. Khodadoust; Y. Natkunam; R. Majzner; C. Mackall; M. Diehn; D. Miklos; A. Alizadeh

Dec 1, 2022Cancer Cell13 influential

2022OpenAlexDirectly related252 citations

CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome

Silvia Arcangeli; Camilla Bove; Claudia Mezzanotte; Barbara Camisa; Laura Falcone; Francesco Manfredi; Eugenia Bezzecchi; Rita El Khoury; Rossana Norata; Francesca Sanvito; Maurilio Ponzoni; Beatrice Greco; Marta Angiola Moresco; Matteo G. Carrabba; Fabio Ciceri; Chiara Bonini; Attilio Bondanza; Monica Casucci

May 3, 2022Journal of Clinical Investigation

2022Semantic ScholarDirectly related26 citations

Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies

Hannah W Song; R. Somerville; D. Stroncek; S. Highfill

Apr 29, 2022International Reviews of Immunology0 influential

2022OpenAlexDirectly related180 citations

Tuning T cell receptor sensitivity through catch bond engineering

Xiang Zhao; Elizabeth Motunrayo Kolawole; Waipan Chan; Yinnian Feng; Xinbo Yang; Marvin H. Gee; Kevin M. Jude; Leah V. Sibener; Polly M. Fordyce; Ronald N. Germain; Brian D. Evavold; K. Christopher García

Apr 7, 2022Science

2022OpenAlexDirectly related54 citations

Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies

Maren Soldierer; Arthur Bister; Corinna Haist; Aniththa Thivakaran; Sevgi Can Cengiz; Stephanie Sendker; Nina Bartels; Antonia Thomitzek; Denise Smorra; Maryam Hejazi; Markus Uhrberg; Kathrin Scheckenbach; Cornelia Monzel; Constanze Wiek; Dirk Reinhardt; Naghmeh Niktoreh; Helmut Hanenberg

Apr 7, 2022Frontiers in Immunology

2022OpenAlexDirectly related118 citations

TCR-T Immunotherapy: The Challenges and Solutions

Yating Liu; Xin Yan; Fan Zhang; Xiaoxia Zhang; Futian Tang; Zhijian Han; Yumin Li

Jan 25, 2022Frontiers in Oncology

2022CrossrefDirectly related0 citations

Chimeric Antigen Receptor T-Cell Therapy (Car T-Cells) in Solid Tumors, Resistance and Success

Elshimali Y

Jan 1, 2022Bioequivalence & Bioavailability International Journal

2021CrossrefDirectly related0 citations

T–Cell Engineering for Chimeric Antigen Receptor T–Cell Therapy in Cancer

Ricardo Gobato; Abhijit Mitra

Dec 20, 2021Open Journal of Radiology and Medical Imaging

2021CrossrefDirectly related207 citations

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany

Nawid Albinger; Jessica Hartmann; Evelyn Ullrich

Sep 1, 2021Gene Therapy